144 related articles for article (PubMed ID: 19373451)
61. The Role of microRNAs in Animal Cell Reprogramming.
Cruz-Santos MC; Aragón-Raygoza A; Espinal-Centeno A; Arteaga-Vázquez M; Cruz-Hernández A; Bako L; Cruz-Ramírez A
Stem Cells Dev; 2016 Jul; 25(14):1035-49. PubMed ID: 27224014
[TBL] [Abstract][Full Text] [Related]
62. Systems biology discoveries using non-human primate pluripotent stem and germ cells: novel gene and genomic imprinting interactions as well as unique expression patterns.
Ben-Yehudah A; Easley CA; Hermann BP; Castro C; Simerly C; Orwig KE; Mitalipov S; Schatten G
Stem Cell Res Ther; 2010 Aug; 1(3):24. PubMed ID: 20699013
[TBL] [Abstract][Full Text] [Related]
63. Application of induced pluripotent stem cells to hematologic disease.
Kim PG; Daley GQ
Cytotherapy; 2009; 11(8):980-9. PubMed ID: 19929461
[TBL] [Abstract][Full Text] [Related]
64. Comparative transcriptomic analysis of endothelial progenitor cells derived from umbilical cord blood and adult peripheral blood: Implications for the generation of induced pluripotent stem cells.
Gao X; Yourick JJ; Sprando RL
Stem Cell Res; 2017 Dec; 25():202-212. PubMed ID: 29156376
[TBL] [Abstract][Full Text] [Related]
65. Human leukemia inhibitory factor produced by the ExpressTec method from rice (Oryza sativa L.) is active in human neural stem cells and mouse induced pluripotent stem cells.
Alfano R; Youngblood BA; Zhang D; Huang N; MacDonald CC
Bioengineered; 2014; 5(3):180-5. PubMed ID: 24776984
[TBL] [Abstract][Full Text] [Related]
66. MePR: a novel human mesenchymal progenitor model with characteristics of pluripotency.
Miceli M; Franci G; Dell'Aversana C; Ricciardiello F; Petraglia F; Carissimo A; Perone L; Maruotti GM; Savarese M; Martinelli P; Cancemi M; Altucci L
Stem Cells Dev; 2013 Sep; 22(17):2368-83. PubMed ID: 23597129
[TBL] [Abstract][Full Text] [Related]
67. A step closer to complete chemical reprogramming for generating iPS cells.
Solanki A; Lee KB
Chembiochem; 2010 Apr; 11(6):755-7. PubMed ID: 20183843
[No Abstract] [Full Text] [Related]
68. Dental pulp stem cells differentiation reveals new insights in Oct4A dynamics.
Ferro F; Spelat R; D'Aurizio F; Puppato E; Pandolfi M; Beltrami AP; Cesselli D; Falini G; Beltrami CA; Curcio F
PLoS One; 2012; 7(7):e41774. PubMed ID: 22844522
[TBL] [Abstract][Full Text] [Related]
69. Cell type-specific expression profile and signaling requirements in early hematopoietic reprogramming.
Kang L; Wu J; Tao Y; Li H; Liu X; Gao S; Wang QF
Stem Cells Dev; 2015 Jun; 24(12):1483-92. PubMed ID: 25751301
[TBL] [Abstract][Full Text] [Related]
70. Generation of an iPS cell line from bone marrow derived mesenchymal stromal cells from an elderly patient.
Megges M; Geissler S; Duda GN; Adjaye J
Stem Cell Res; 2015 Nov; 15(3):565-8. PubMed ID: 26987921
[TBL] [Abstract][Full Text] [Related]
71. Optimized surface markers for the prospective isolation of high-quality hiPSCs using flow cytometry selection.
Abujarour R; Valamehr B; Robinson M; Rezner B; Vranceanu F; Flynn P
Sci Rep; 2013; 3():1179. PubMed ID: 23378912
[TBL] [Abstract][Full Text] [Related]
72. Letter to the Editor: Production of Mature Healthy Hematopoietic Cells from Induced Pluripotent Stem Cells Derived from an AML Diagnostic Sample Containing the t(8;21) Translocation.
Hoffmann D; Göhring G; Heuser M; Ganser A; Schambach A; Morgan MA
Stem Cells; 2016 Mar; 34(3):797-9. PubMed ID: 26388310
[No Abstract] [Full Text] [Related]
73. Pluripotency Genes and Their Functions in the Normal and Aberrant Breast and Brain.
Seymour T; Twigger AJ; Kakulas F
Int J Mol Sci; 2015 Nov; 16(11):27288-301. PubMed ID: 26580604
[TBL] [Abstract][Full Text] [Related]
74. Career moves: induced pluripotent cells from human aortic smooth muscle cells can efficiently redifferentiate into parental phenotype.
Kishore R; Krishnamurthy P; Losordo DW
Circ Res; 2010 Jan; 106(1):7-9. PubMed ID: 20056938
[No Abstract] [Full Text] [Related]
75. Stem cells: The growing pains of pluripotency.
Hayden EC
Nature; 2011 May; 473(7347):272-4. PubMed ID: 21593837
[No Abstract] [Full Text] [Related]
76. PDGF-AB and 5-Azacytidine induce conversion of somatic cells into tissue-regenerative multipotent stem cells.
Chandrakanthan V; Yeola A; Kwan JC; Oliver RA; Qiao Q; Kang YC; Zarzour P; Beck D; Boelen L; Unnikrishnan A; Villanueva JE; Nunez AC; Knezevic K; Palu C; Nasrallah R; Carnell M; Macmillan A; Whan R; Yu Y; Hardy P; Grey ST; Gladbach A; Delerue F; Ittner L; Mobbs R; Walkley CR; Purton LE; Ward RL; Wong JW; Hesson LB; Walsh W; Pimanda JE
Proc Natl Acad Sci U S A; 2016 Apr; 113(16):E2306-15. PubMed ID: 27044077
[TBL] [Abstract][Full Text] [Related]
77. Scalable topographies to support proliferation and Oct4 expression by human induced pluripotent stem cells.
Reimer A; Vasilevich A; Hulshof F; Viswanathan P; van Blitterswijk CA; de Boer J; Watt FM
Sci Rep; 2016 Jan; 6():18948. PubMed ID: 26757610
[TBL] [Abstract][Full Text] [Related]
78. Reprogramming Malignant Cancer Cells toward a Benign Phenotype following Exposure to Human Embryonic Stem Cell Microenvironment.
Zhou S; Abdouh M; Arena V; Arena M; Arena GO
PLoS One; 2017; 12(1):e0169899. PubMed ID: 28068409
[TBL] [Abstract][Full Text] [Related]
79. Experimental limitations using reprogrammed cells for hematopoietic differentiation.
Seiler K; Tsuneto M; Melchers F
J Biomed Biotechnol; 2011; 2011():895086. PubMed ID: 22187531
[TBL] [Abstract][Full Text] [Related]
80. Method for the Generation of Induced Hematopoietic Stem Cells.
Olender L; Levy K; Gazit R
Methods Mol Biol; 2021; 2185():399-410. PubMed ID: 33165863
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
